Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Locally Advanced Non-resectable Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Tesetaxel|DRUG: Tesetaxel|DRUG: Capecitabine
Sponsor: Genta Incorporated